期刊
CANCER INVESTIGATION
卷 38, 期 10, 页码 559-564出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/07357907.2020.1833212
关键词
Biochemical recurrence; hormonal therapy; prostate cancer; radical prostatectomy; smoking
类别
资金
- Smoking Research Foundation, Japan
We analyzed the association between smoking and oncological outcome after radical prostatectomy with neoadjuvant hormonal therapy. This study included men who had undergone radical prostatectomy with neoadjuvant hormonal therapy between 2003 and 2016. We evaluated the association between clinicopathological factors and smoking status as well as the prognostic significance of smoking status in biochemical recurrence. The patients' backgrounds were comparable between smokers and nonsmokers. Smoking status were identified as significant risk factors of biochemical recurrence. Smoking was a risk factor of biochemical recurrence, suggesting that smoking may promote cancer recurrence after surgical treatment combined with hormonal therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据